Ingenuity Licenses Pathway Software, Database to Japanese Pharma | GenomeWeb
NEW YORK (GenomeWeb News) - Pathway informatics firm Ingenuity Systems said today that it has inked a global licensing agreement with Tokyo-based drug maker Astellas Pharma.
Under the terms of the agreement, Astellas will use Ingenuity's Pathway Analysis software and will have access to the accompanying Pathway Knowledge Base database, which catalogs information about the relationships between genes, proteins, cells, tissues and diseases.
No financial terms of the agreement were released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.